How to buy IRadimed Corporation stock | $27.81

IRadimed Corporation is a medical devices business based in the US. IRadimed Corporation shares (IRMD) are listed on the NASDAQ and all prices are listed in US Dollars. IRadimed Corporation employs 110 staff and has a trailing 12-month revenue of around 0.00.

IRadimed Corporation stock price (NASDAQ: IRMD)

Use our graph to track the performance of IRMD stocks over time.

IRadimed Corporation shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$27.81
52-week range	$20.46 - $39.96
50-day moving average	$31.34
200-day moving average	$26.93
Wall St. target price	$33.00
PE ratio	419.7531
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.08

Buy IRadimed Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy IRadimed Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of IRadimed Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IRadimed Corporation price performance over time

Historical closes compared with the close of $27.81 from 2021-05-28

1 week (2021-07-23)	N/A
1 month (2021-07-02)	-6.21%
3 months (2021-05-03)	-1.90%
6 months (2021-01-30)	N/A

1 year (2020-07-30)	N/A
2 years (2019-07-30)	N/A
3 years (2018-07-30)	N/A
5 years (2016-07-30)	N/A

Is IRadimed Corporation under- or over-valued?

Valuing IRadimed Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IRadimed Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IRadimed Corporation's P/E ratio

IRadimed Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 420x. In other words, IRadimed Corporation shares trade at around 420x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

IRadimed Corporation's PEG ratio

IRadimed Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IRadimed Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

IRadimed Corporation's EBITDA

IRadimed Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 million.

The EBITDA is a measure of a IRadimed Corporation's overall financial performance and is widely used to measure a its profitability.

IRadimed Corporation financials

Revenue TTM	$32.3 million
Operating margin TTM	9.25%
Gross profit TTM	$23.6 million
Return on assets TTM	2.65%
Return on equity TTM	1.63%
Profit margin	3.06%
Book value	$5.12
Market capitalisation	$418.6 million

TTM: trailing 12 months

Shorting IRadimed Corporation shares

There are currently 92,406 IRadimed Corporation shares held short by investors – that's known as IRadimed Corporation's "short interest". This figure is 8.6% down from 101,053 last month.

There are a few different ways that this level of interest in shorting IRadimed Corporation shares can be evaluated.

IRadimed Corporation's "short interest ratio" (SIR)

IRadimed Corporation's "short interest ratio" (SIR) is the quantity of IRadimed Corporation shares currently shorted divided by the average quantity of IRadimed Corporation shares traded daily (recently around 57040.740740741). IRadimed Corporation's SIR currently stands at 1.62. In other words for every 100,000 IRadimed Corporation shares traded daily on the market, roughly 1620 shares are currently held short.

However IRadimed Corporation's short interest can also be evaluated against the total number of IRadimed Corporation shares, or, against the total number of tradable IRadimed Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IRadimed Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IRadimed Corporation shares in existence, roughly 10 shares are currently held short) or 0.0216% of the tradable shares (for every 100,000 tradable IRadimed Corporation shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IRadimed Corporation.

Find out more about how you can short IRadimed Corporation stock.

IRadimed Corporation share dividends

We're not expecting IRadimed Corporation to pay a dividend over the next 12 months.

IRadimed Corporation share price volatility

Over the last 12 months, IRadimed Corporation's shares have ranged in value from as little as $20.46 up to $39.96. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRadimed Corporation's is 1.0152. This would suggest that IRadimed Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

IRadimed Corporation overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. .

Frequently asked questions

What percentage of IRadimed Corporation is owned by insiders or institutions?
Currently 48.944% of IRadimed Corporation shares are held by insiders and 40.835% by institutions. How many people work for IRadimed Corporation?
Latest data suggests 110 work at IRadimed Corporation. When does the fiscal year end for IRadimed Corporation?
IRadimed Corporation's fiscal year ends in December. Where is IRadimed Corporation based?
IRadimed Corporation's address is: 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708 What is IRadimed Corporation's ISIN number?
IRadimed Corporation's international securities identification number is: US46266A1097 What is IRadimed Corporation's CUSIP number?
IRadimed Corporation's Committee on Uniform Securities Identification Procedures number is: 46266A109